NO0010571680 (NO0010571680)

$51.2B
Market Cap
5.2
P/E Ratio
1.05
Beta
10.93%
Dividend Yield
Piotroski 7/9Altman Z 8.6 SafeROIC−WACC +8.2%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 8.6 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation framework demonstrates robust efficiency, evidenced by a return on invested capital of 19.3% that significantly outpaces the weighted average cost of capital at 11.2%, generating an economic spread of +8.2%. This profitability is underpinned by high operating leverage, reflected in net margins of 19.4% and gross margins of 26.5%, though revenue growth has contracted slightly to -1.3% year-over-year. Financial stability appears strong given a Piotroski F-Score of 7/9 and an Altman Z-Score of 8.6, suggesting the entity maintains healthy solvency despite recent top-line softness; however, DuPont decomposition indicates that returns are primarily driven by margin expansion rather than asset turnover or financial leverage.

Valuation metrics present a distinct divergence between historical norms and intrinsic value models. The current price-to-earnings multiple of 5.2x sits at an extreme compression relative to typical sector expectations for firms with this quality profile, implying the market is pricing in persistent execution risks despite the company's superior capital efficiency. A discounted cash flow analysis suggests a fair value of $32, which would necessitate a substantial re-rating if current growth constraints resolve and margins stabilize. The disparity between the low multiple and implied DCF targets indicates that investor sentiment may be disproportionately focused on near-term revenue headwinds rather than the underlying quality of earnings generation.

Risk assessment reveals a mixed picture where fundamental strength contrasts with recent performance trends. While the high Altman Z-Score mitigates immediate distress concerns, the negative revenue growth delta introduces uncertainty regarding future cash flow sustainability that is not fully captured in static margin metrics. The combination of a low valuation multiple and strong balance sheet creates an asymmetric risk-reward profile contingent on whether the market corrects its pessimistic outlook or if further top-line deterioration erodes the current economic spread.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9.2%11.2%13.2%
2%$70$54$44
3%$79$59$47
4%$91$66$51

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.2%, terminal growth 3%. Fair value $59 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
8.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

26.5%
Gross Margin
19.4%
Net Margin
19.3%
ROIC
11.2%
WACC
ROIC − WACC Spread: +8.2%— Positive value creation spread.
-1.3%
Revenue Growth (YoY)
+4.5%
Earnings Growth (YoY)
1.5B
Free Cash Flow
66%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.37x
Debt / Equity
0.85x
Current Ratio
7.3x
Interest Coverage
-0.1x
Net Debt / EBITDA
2.94%
FCF Yield
2.0B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.59
Act: $0.53
-10.6%
Q3
✗ Miss
Est: $0.68
Act: $0.58
-14.8%
Q2
✓ Beat
Est: $0.53
Act: $0.56
+5.2%
Q1
✗ Miss
Est: $0.44
Act: $0.43
-2.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

9.6
Forward P/E
PEG Ratio
1.60
Price/Book
533905
Avg Volume
$137.10
52W High
$55.25
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$11M
Tracked Passive Exposure
2
ETFs Holding NO0010571680
0.00%
Avg Weight in ETFs
$222B
Total ETF AUM

When investors buy or sell ETFs like IEFA or IXUS, the fund manager is mechanically forced to buy or sell NO0010571680 shares regardless of NO0010571680's individual fundamentals. We estimate $11M of passive capital is structurally linked to NO0010571680 through 2 tracked ETFs. Passive flows have a limited but growing influence on NO0010571680's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NO0010571680 to visualize passive redemption contagion across ETFs and collateral stocks.

NO0010571680 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NO0010571680EpicenterIEFAETFIXUSETFNL0010273215Low RiskTW0002330008Low RiskCH0012032048Low RiskGB0005405286High Risk066922519Unknown
NO0010571680 Price Drop (%)0

If NO0010571680 (NO0010571680) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 2 ETFs with NO0010571680. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NO0010571680 Ownership Dynamics

Ticker
NO0010571680

Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NO0010571680 Capital Efficiency

How efficiently does NO0010571680 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$1.5B
EBITDA
$2.0B
FCF Conversion
76%
Reinvestment Rate
24%
76% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
19.3%
ROIC − WACC Spread
8.2%

NO0010571680 converts 76% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 8.2% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare NO0010571680 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.